Re: The decriminalisation of the good cannabis plant continues apace: Announcement this AM of two more - Archived Message
Posted by Gerard on November 12, 2019, 10:46 am, in reply to "The decriminalisation of the good cannabis plant continues apace: Announcement this AM of two more -"
"My main bug bear with these new guidelines is that cannabis-based medicine will still not be available for chronic pain. This is an area where it is clearly effective, and these new guidelines were called a massive missed opportunity by the End Our Pain campaign. The guidelines are only recommending two drugs, both manufactured by the same company, GW Pharmaceuticals. They are Sativex (1:1 THC:CBD) and Epidyolex (CBD Dominant). Ironically, in the new guidelines price is stated as a cause for concern, and NICE mention this had initially restricted the route to market of CBPMs until GW agreed to lower their cost to the NHS. Patients, Doctors and indeed NICE themselves should know that the treatment cost per patient is massively marked up when a CBD or a 1:1 strain can be grown at home for a fraction of 1% of the cost.. https://ismokemag.co.uk/uk-cannabis-legalisation-fact-or-farce/ *Italics mine.
|
|